Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02110043
Other study ID # LOCATO-MCI-tDCS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2014
Est. completion date October 2017

Study information

Verified date May 2021
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate whether a combination of intensive training of visual-spatial abilities (LOCATO task) with anodal transcranial direct current stimulation (tDCS) leads to an improvement in learning and memory in patients with mild cognitive impairment (MCI) and to examine the underlying neuronal mechanism.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date October 2017
Est. primary completion date August 2017
Accepts healthy volunteers No
Gender All
Age group 50 Years to 90 Years
Eligibility Inclusion Criteria (MCI patients): - right handedness - amnestic and amnestic plus MCI with: 1. subjective memory impairment; 2. objective memory difficulties, at least 1 SD below gender, age and education adjusted standard values; 3. relatively normal performance in other cognitive domains; 4. no constraints in activities of daily livings 5. age: 50-90 years Exclusion Criteria: - severe internal or psychiatric disease - epilepsy - other severe neurological diseases, e.g. previous major stroke or brain tumor - DMS-IV manifest dementia - contraindication for MRT (claustrophobia, metallic implants, tattoos)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
tDCS
transcranial direct current stimulation (tDCS)
Behavioral:
training
intensive training of visual-spatial abilities (in LOCATO task)

Locations

Country Name City State
Germany Charite Universitätsmedizin Berlin Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Külzow N, Kerti L, Witte VA, Kopp U, Breitenstein C, Flöel A. An object location memory paradigm for older adults with and without mild cognitive impairment. J Neurosci Methods. 2014 Nov 30;237:16-25. doi: 10.1016/j.jneumeth.2014.08.020. Epub 2014 Aug 28. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Performance in LOCATO task (Visual-spatial learning and memory) after a combination of intensive visual-spatial training and tDCS Investigation whether the combination of intensive visual-spatial training (LOCATO task) and tDCS leads to improvement of visual-spatial learning and memory measured by performance in LOCATO task after end of a 3 day period of training compared to sham stimulation. immediately after end of a 3-day period of training in tDCS condition vs sham condition
Secondary long term effects long term effects measured by performance in LOCATO task in tDCS condition after end of cognitve training and after 1 month compared to control conditions after 1 month vs baseline
Secondary functional changes: Connectivity Connectivity (measured by resting-state fMRT and correlation analysis) at baseline compared to end of 3 day period of training end of 3-day cognitive training vs baseline
Secondary cortical excitability cortical excitability measured by transcranial magnetic stimulation (TMS) at baseline
Secondary Quality of Life quality of life as measured by standardized questionaire at baseline compared to quality of life measured 1 month after intervention (training and stimulation vs. training and sham-stimualtion) after 1 month vs baseline
Secondary memory memory performance tested at baseline compared to memory performance after the end of a 3-day cognitive training period and after 1 month (posttraining) in training and stimulation vs. training and sham stimulation immediately after end of 3-day of cognitive training, after 1 month vs. baseline
Secondary affective state affective state measured at baseline compared to affective state measured after the end of a 3-day cognitve training period and after 1 month (posttraining) in training and stimulation vs. training and sham stimulation immediately after the end of 3-day cognitive training, after 1 month vs. baseline
Secondary genotyping of learning related polymorphisms To assess predictors of positive reaction to brain stimulation, genotyping of several learning related polymorphisms will be performed (i.e., APOE, BDNF Val66Met, COMT Val158Met). once
See also
  Status Clinical Trial Phase
Completed NCT00934531 - Donepezil and the Risk of Falls in Seniors With Cognitive Impairment N/A
Withdrawn NCT05033912 - A Study of CST-2032 in Subjects With Cognitive Impairment Phase 1
Recruiting NCT02854033 - Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Completed NCT01902004 - Brain Aging and Treatment Response in Geriatric Depression Phase 4
Completed NCT01212692 - Effects of Mental Stimulation in Patients With Mild Cognitive Impairment Phase 2
Recruiting NCT00544791 - The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment Phase 2
Withdrawn NCT04055532 - Biomarkers in Neurodegenerative Diseases
Terminated NCT02180529 - The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment N/A
Completed NCT05108922 - A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4) Phase 3
Recruiting NCT05865340 - To Exam the Efficacy of Oral Health and Mediterranean Diet Interventions in Preventing Cognitive Decline Among Older Adults With Mild Cognitive Impairment N/A
Recruiting NCT06453941 - Yizhi Baduanjin for Patients With Cognitive Impairment N/A
Completed NCT06417034 - Hand Training Device For Cognitive Care N/A
Completed NCT01383161 - 18-Month Study of Memory Effects of Curcumin Phase 2
Completed NCT01299766 - Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment Phase 3
Withdrawn NCT05321498 - Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation Phase 2
Completed NCT04748666 - PST for Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia N/A
Recruiting NCT03138018 - Aging Stereotypes and Prodromal Alzheimer's Disease N/A
Withdrawn NCT01891383 - Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
Recruiting NCT03448055 - Nutritional Intervention With the Dietary Supplement, Immunocal® in MCI Patients: Promotion of Brain Health N/A
Completed NCT01231971 - Alzheimer's Disease Neuroimaging Initiative 2